BioSpace News Archive

Policy

Centene’s Oregon Subsidiary Receives Preliminary Award For Expanded Oregon Health Plan Contract

Centene Corporation announced that its Oregon subsidiary, Trillium Community Health Plan, has been notified by the Oregon Health Authority of OHA’s intent to award Trillium a contract to serve as a coordinated care organization for six counties in the state.

July 10, 2019
·
10 min read
Policy

Ortho Clinical Diagnostics, Lab Leaders, Executives to Examine How Data Is Transforming Labs and Health Care

Ortho to Host Industry Conferences: ‘Lab Leader Summit’ and ‘Healthcare Management in a Digital World’

July 10, 2019
·
3 min read
Drug Development

Syndax Pharmaceuticals Announces FDA Clearance of IND Application for Targeted Menin Inhibitor SNDX-5613 for Relapsed/Refractory Acute Leukemias

SNDX-5613 is a potent, highly selective, oral inhibitor of the interaction of Menin with the Mixed Lineage Leukemia (MLL) protein

July 10, 2019
·
5 min read
Biotech Bay

Alcon Standardizes on Veeva Vault CDMS for Clinical Data Management

Top 20 medical device company selects Vault CDMS for greater agility in clinical trial management

July 10, 2019
·
4 min read
Policy

Horizon Therapeutics plc Submits Teprotumumab Biologics License Application (BLA) for the Treatment of Active Thyroid Eye Disease (TED)

Horizon Therapeutics plc announced that it has submitted a Biologics License Application to the U.S. Food and Drug Administration for its investigational medicine teprotumumab for the treatment of active thyroid eye disease.

July 10, 2019
·
7 min read
Business

Scandinavian ChemoTech Expands its Presence in the Philippines by Signing a Distribution Agreement Focusing on the Public Healthcare System

ChemoTech has signed a distribution agreement with BASEMED KARE Inc. (BASEMED), and thereby increased its efforts to establish a stronger market presence in the Public Healthcare of the Philippines.

July 10, 2019
·
1 min read
Horizon Therapeutics plc Announces Proposed Private Offering of Senior Notes

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that Horizon Pharma USA, Inc., its wholly-owned subsidiary, intends, subject to market and other considerations, to offer $500 million aggregate principal amount of senior notes due 2027.

July 10, 2019
·
3 min read
Drug Development

TARIS Initiates Clinical Trial of TAR-200 in Combination with Opdivo® (nivolumab) for Patients with Muscle-Invasive Bladder Cancer

TARIS Bio™ today announced the dosing of the first patient in a Phase 1b clinical trial evaluating the investigational product TAR-200 in combination with Opdivo® (nivolumab), a programmed death-1 (PD-1) immune checkpoint inhibitor from Bristol-Myers Squibb.

July 10, 2019
·
3 min read
Business

Spectrum Therapeutics partners with Canadian Mental Health Association’s Not Myself Today initiative

Spectrum Therapeutics (“Spectrum”), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the “Company” or “Canopy Growth”) is pleased to announce a partnership with the Canadian Mental Health Association (“CMHA”).

July 10, 2019
·
10 min read
BioMidwest

Treatment Benefits of the remedē® System Sustained Through 36 Months in Patients with Central Sleep Apnea

Respicardia Also Initiates 500-Patient Prospective, Global, Single-Arm Longitudinal Study

July 10, 2019
·
6 min read